quinoxalines has been researched along with Delusional Disorder in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gunn, RN; Howes, O; Kapur, S; Marques, TR; Natesan, S; Niccolini, F; Politis, M; Rabiner, EA; Searle, GE | 1 |
| George, TP; Lising-Enriquez, K | 1 |
2 other study(ies) available for quinoxalines and Delusional Disorder
| Article | Year |
|---|---|
Phosphodiesterase 10A in Schizophrenia: A PET Study Using [(11)C]IMA107.
Topics: Adult; Brain; Chronic Disease; Female; Heterocyclic Compounds, 2-Ring; Humans; Male; Phosphoric Diester Hydrolases; Positron Emission Tomography Computed Tomography; Psychiatric Status Rating Scales; Quinoxalines; Reference Values; Schizophrenia, Paranoid | 2016 |
Treatment of comorbid tobacco use in people with serious mental illness.
Topics: Adult; Benzazepines; Bupropion; Comorbidity; Counseling; Dopamine Uptake Inhibitors; Female; Follow-Up Studies; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Schizophrenia, Paranoid; Smoking; Smoking Cessation; Varenicline | 2009 |